Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns

Stock Track01-30

Recursion Pharmaceuticals, Inc. (RXRX) stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the artificial intelligence (AI) industry.

The biotech company, which focuses on AI-driven drug discovery, has garnered attention for its involvement in the rapidly growing AI healthcare market. However, recent developments, such as the introduction of DeepSeek's new AI model, have fueled market jitters and an "overreaction" from investors regarding the implications for AI-related companies.

Additionally, healthcare technology stocks, including Recursion Pharmaceuticals, faced market pressure throughout 2024. Despite this, analysts remain optimistic about the company's prospects, citing its acquisition of AI biotech startup Exscientia, a robust pipeline with over 10 clinical and preclinical programs, and the potential for achieving significant milestones in the next 18 months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131203822?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-30 03:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131203822","market":"us","top_or_hot":-1,"title":"Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns","media":"Stock Track","content":"<p>Recursion Pharmaceuticals, Inc. (RXRX) stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the artificial intelligence (AI) industry.</p>\n\n<p>The biotech company, which focuses on AI-driven drug discovery, has garnered attention for its involvement in the rapidly growing AI healthcare market. However, recent developments, such as the introduction of DeepSeek's new AI model, have fueled market jitters and an \"overreaction\" from investors regarding the implications for AI-related companies.</p>\n\n<p>Additionally, healthcare technology stocks, including Recursion Pharmaceuticals, faced market pressure throughout 2024. Despite this, analysts remain optimistic about the company's prospects, citing its acquisition of AI biotech startup Exscientia, a robust pipeline with over 10 clinical and preclinical programs, and the potential for achieving significant milestones in the next 18 months.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n2025-01-30 03:02 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recursion Pharmaceuticals, Inc. (RXRX) stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RXRX","symbol_name":"Recursion Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1131203822","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131203822","pubTimestamp":1738177364,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Recursion Pharmaceuticals, Inc.  stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the artificial intelligence  industry.The biotech company, which focuses on AI-driven drug discovery, has garnered attention for its involvement in the rapidly growing AI healthcare market. However, recent developments, such as the introduction of DeepSeek's new AI model, have fueled market jitters and an \"overre","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc."},"translate_title":"由于人工智能市场波动和医疗保健技术担忧，Recursion Pharmaceuticals股价暴跌5.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RXRX":1},"content_text":"Recursion Pharmaceuticals, Inc. (RXRX) stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the artificial intelligence (AI) industry.\nThe biotech company, which focuses on AI-driven drug discovery, has garnered attention for its involvement in the rapidly growing AI healthcare market. However, recent developments, such as the introduction of DeepSeek's new AI model, have fueled market jitters and an \"overreaction\" from investors regarding the implications for AI-related companies.\nAdditionally, healthcare technology stocks, including Recursion Pharmaceuticals, faced market pressure throughout 2024. Despite this, analysts remain optimistic about the company's prospects, citing its acquisition of AI biotech startup Exscientia, a robust pipeline with over 10 clinical and preclinical programs, and the potential for achieving significant milestones in the next 18 months.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131203822"}